|Mr. Kenneth S. Siegel||CEO & Director||296.25k||N/A||1956|
|Mr. Thomas C. Chesterman||Exec. VP, CFO, Treasurer & Assistant Sec.||246.32k||N/A||1959|
|Ms. Kim Patrice Wolin||Exec. VP of Operations & Sec.||90.84k||N/A||1955|
|Dr. Steven C. Krause Ph.D.||Exec. VP of Sales & Marketing||240.33k||N/A||1960|
|Mr. Paul M. Palz||VP & Corp. Controller||N/A||N/A||N/A|
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait that limits reproduction of male and female rats. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
SenesTech, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.